Overview
- The research describing the device has been peer reviewed and published in Nature Scientific Reports.
- Laboratory evaluations differentiated resistant and susceptible strains of E. coli and B. subtilis using ampicillin and tetracycline.
- The method also worked on urine samples spiked with E. coli, indicating potential for clinical use.
- Clinical validation is currently underway at the IIT Madras Institute Hospital.
- The team plans to commercialise the technology through Kaappon Analytics for deployment in smaller clinics and rural healthcare centres.